OTCQX:MRVFF - Post by User
Comment by
geos571on Aug 20, 2015 10:15am
150 Views
Post# 24035334
RE:News..Topical includes DMSO in Patent
RE:News..Topical includes DMSO in Patent Ibufoam should be available in a spray can and have a similar price point to Voltaren. It should also be sold OTC . Nuvo has the cash reserves to bring this market and should without a partner .
About IBUFOAM
IBUFOAM has been developed to treat acute and chronic pain conditions such as sprains and strains and osteoarthritis (OA). IBUFOAM is a topical ibuprofen foam formulation that combines a transdermal carrier DMSO with 5% the NSAID ibuprofen and delivers the active drug through the skin directly to the site of inflammation and pain.
Read more at https://www.stockhouse.com/news/press-releases/2015/08/20/nuvo-research%C2%AE-announces-u-s-patent-for-topical-foamed-formulations-that#zgivkTBeRq2rKQF7.99